85-year-old man with epistaxis.
作者信息
Butts Matthew J, Skalski Joseph H, Wittich Christopher M
机构信息
Mayo School of Graduate Medical Education, Mayo Clinic, Rochester, MN, USA.
出版信息
Mayo Clin Proc. 2011 Apr;86(4):344-7. doi: 10.4065/mcp.2010.0449.
Abstract
摘要
相似文献
1
85-year-old man with epistaxis.85岁男性，鼻出血。
Mayo Clin Proc. 2011 Apr;86(4):344-7. doi: 10.4065/mcp.2010.0449.
2
Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.意义未明的单克隆丙种球蛋白病与多发性骨髓瘤
JAMA Oncol. 2015 May;1(2):174-5. doi: 10.1001/jamaoncol.2015.33.
3
[Monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma].意义未明的单克隆丙种球蛋白病（MGUS）和多发性骨髓瘤
Praxis (Bern 1994). 2012 Nov 28;101(24):1521-9; quiz 1530-1. doi: 10.1024/1661-8157/a001137.
4
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.意义未明的单克隆丙种球蛋白病和冒烟型多发性骨髓瘤
Hematol Oncol Clin North Am. 2014 Oct;28(5):775-90. doi: 10.1016/j.hoc.2014.06.005. Epub 2014 Jul 22.
5
The screening imperative for multiple myeloma.多发性骨髓瘤的筛查必要性
Nature. 2020 Nov;587(7835):S63. doi: 10.1038/d41586-020-03227-y.
6
Management of newly diagnosed myeloma.新诊断骨髓瘤的管理
Hematol Oncol Clin North Am. 2007 Dec;21(6):1141-56, ix-x. doi: 10.1016/j.hoc.2007.08.008.
7
Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.多发性骨髓瘤患者伴意义未明的单克隆丙种球蛋白血症的发生率、临床经过和预后。
Blood. 2011 Sep 15;118(11):2985-7. doi: 10.1182/blood-2011-04-349175. Epub 2011 Jul 15.
8
Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).意义未明的单克隆丙种球蛋白血症（MGUS）和冒烟型多发性骨髓瘤（SMM）的治疗。
Oncology (Williston Park). 2011 Jun;25(7):578-86.
9
Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities.多发性骨髓瘤前驱疾病：当前的临床与流行病学见解及未来机遇
Oncology (Williston Park). 2011 Jun;25(7):589-90.
10
Diagnostics: The early bird.
Nature. 2011 Dec 14;480(7377):S36-7. doi: 10.1038/480S36a.
本文引用的文献
1
Sister Mary Joseph and her nodule: historical and clinical perspective.玛丽·约瑟夫修女及其结节：历史与临床视角
Am J Med Sci. 2009 Apr;337(4):271-3. doi: 10.1097/MAJ.0b013e3181954187.
2
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.冒烟型（无症状）多发性骨髓瘤的临床病程及预后
N Engl J Med. 2007 Jun 21;356(25):2582-90. doi: 10.1056/NEJMoa070389.
3
Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size.意义未明的单克隆丙种球蛋白病：恶性转化的预测因素及一种以M蛋白大小逐渐增加为特征的进展型的识别。
Mayo Clin Proc. 2007 Apr;82(4):428-34. doi: 10.4065/82.4.428.
4
Guidelines on the diagnosis and management of multiple myeloma 2005.2005年多发性骨髓瘤诊断与管理指南
Br J Haematol. 2006 Feb;132(4):410-51. doi: 10.1111/j.1365-2141.2005.05867.x.
5
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.血清游离轻链比值是意义未明的单克隆丙种球蛋白病病情进展的独立危险因素。
Blood. 2005 Aug 1;106(3):812-7. doi: 10.1182/blood-2005-03-1038. Epub 2005 Apr 26.
6
7
Review of 1027 patients with newly diagnosed multiple myeloma.对1027例新诊断的多发性骨髓瘤患者的回顾。
Mayo Clin Proc. 2003 Jan;78(1):21-33. doi: 10.4065/78.1.21.
8
A long-term study of prognosis in monoclonal gammopathy of undetermined significance.意义未明的单克隆丙种球蛋白病预后的长期研究。
N Engl J Med. 2002 Feb 21;346(8):564-9. doi: 10.1056/NEJMoa01133202.
9
Amyloidosis.淀粉样变性
Hematol Oncol Clin North Am. 1999 Dec;13(6):1211-33, ix. doi: 10.1016/s0889-8588(05)70122-2.
10
The accuracy of the physical examination in the diagnosis of suspected ascites.体格检查对疑似腹水诊断的准确性。
JAMA. 1982 Feb 26;247(8):1164-6.
Zotero 插件